Thomas Harrity

2.2k citations

23 papers · 1.1k indexed · h-index 17

Impact in

Biochemistry top 10%
Organic Chemistry top 10%
- Organophosphorus compounds synthesis

Papers in

Biochemistry 3
- Lipid metabolism and biosynthesis 3
Pharmacology 3
- Pharmacological Effects of Natural Compounds 3

Co-authors: Carl P. Ciosek Scott A. Biller Eric M. Gordon John K. Dickson David R. Magnin Lori Kunselman Kern G. Jolibois Cornelia J. Forster
Journals: Journal of Medicinal Chemistry (8 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of the American Chemical Society (2 papers)ACS Medicinal Chemistry Letters (1 paper)Journal of Bone and Mineral Research (1 paper)
Partner nations: United States Germany Malaysia

In The Last Decade

Thomas Harrity

23 papers receiving 1.0k citations

Peers

Countries citing papers authored by Thomas Harrity

Since Specialization

Citations

This map shows the geographic impact of Thomas Harrity's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Harrity with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Harrity more than expected).

Fields of papers citing papers by Thomas Harrity

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Harrity. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Harrity. The network helps show where Thomas Harrity may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Harrity, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Harrity Line = papers co-authored together Thomas Harrity links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetes Bioorganic & Medicinal Chemistry Letters ·Olena Koliennikova, Wei Meng, Aberra Fura, Thomas Harrity, Aiying Wang, Robert Zahler, Mark Kirby, Lawrence G. Hamann	2010	47
2	Discovery of 6-(Aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as Potent, Selective Dipeptidyl Peptidase-4 (DPP4) Inhibitors Journal of Medicinal Chemistry ·Wei Meng, Olena Koliennikova, Daniel Erlacher, Aberra Fura, Thomas Harrity, Jovita Marcinkeviciene, Stephen P. O’Connor, James Tamura, Dianlin Xie, Yaqun Zhang, Herbert E. Klei, Kevin Kish, Carolyn A. Weigelt, V. Ruiz Sancho, Aiying Wang, Robert Zahler, Mark Kirby, Lawrence G. Hamann	2010	41
3	Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP) Bioorganic & Medicinal Chemistry Letters ·Richard Sulsky, David R. Magnin, Yanting Huang, Ligaya M. Simpkins, Prakash C. Taunk, Manorama M. Patel, Yeheng Zhu, Terry R. Stouch, Donna Bassolino‐Klimas, Rex A. Parker, Thomas Harrity, Robert H. Stoffel, David S. Taylor, Thomas Lavoie, Kevin Kish, Bruce L. Jacobson, S. Sheriff, Leonard P. Adam, William R. Ewing, Jeffrey A. Robl	2006	126
4	Muraglitazar, a Novel Dual ( / ) Peroxisome Proliferator-Activated Receptor Activator, Improves Diabetes and Other Metabolic Abnormalities and Preserves -Cell Function in db/db Mice Diabetes ·Thomas Harrity	2006	2
5	5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP Bioorganic & Medicinal Chemistry Letters ·Richard Sulsky, Jeffrey A. Robl, Scott A. Biller, Thomas Harrity, John R. Wetterau, Fergal Connolly, Kern G. Jolibois, Lori Kunselman	2004	26
6	Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agents Bioorganic & Medicinal Chemistry Letters ·David R. Magnin, Scott A. Biller, John R. Wetterau, Jeffrey A. Robl, John K. Dickson, Prakash C. Taunk, Thomas Harrity, R. Michael Lawrence, Daniel Toribio-Avedillo, Olga Daschenko, Ni Luh Putu Julia Kartika Candra Kirana, Olga M. Fryszman, Fergal Connolly, Kern G. Jolibois, Lori Kunselman	2003	16
7	The Ability of Statins to Inhibit Bone Resorption Is Directly Related to Their Inhibitory Effect on HMG-CoA Reductase Activity Journal of Bone and Mineral Research ·Ada Staal, Julie C. Frith, M. H. French, L.C. Murguia, Timur Güngör, Thomas Harrity, Joseph Tamasi, Michael J. Rogers, Jean H.M. Feyen	2003	144
8	A Novel Series of Highly Potent Benzimidazole-Based Microsomal Triglyceride Transfer Protein Inhibitors Journal of Medicinal Chemistry ·Jeffrey A. Robl, Richard Sulsky, Chong‐Qing Sun, Ligaya M. Simpkins, Olga Daschenko, John K. Dickson, Ying Chen, David R. Magnin, Prakash C. Taunk, William A. Slusarchyk, Scott A. Biller, Shih-Jung Lan, Fergal Connolly, Lori Kunselman, Georg Schmidt, Haris Jamil, David Gordon, Thomas Harrity, John R. Wetterau	2001	49
9	Orally Active Squalene Synthase Inhibitors: Bis((acyloxy)alkyl) Prodrugs of the α-Phosphonosulfonic Acid Moiety Journal of Medicinal Chemistry ·John K. Dickson, Scott A. Biller, David R. Magnin, Edward W. Petrillo, Naseebullah Barozai, Maegan L. Rinehart, Shih-Jung Lan, J. Kent Rinehart, Richard E. Gregg, Thomas Harrity, Kern G. Jolibois, Stephen Kalinowski, Lori Kunselman, Kasim A. Mookhtiar, Carl P. Ciosek	1996	44
10	α-Phosphonosulfonic Acids: Potent and Selective Inhibitors of Squalene Synthase Journal of Medicinal Chemistry ·David R. Magnin, Scott A. Biller, Ying Chen, John K. Dickson, Olga M. Fryszman, R. Michael Lawrence, Ni Luh Putu Julia Kartika Candra Kirana, Ellen Sieber-McMaster, Richard Sulsky, Sarah C. Traeger, Maegan L. Rinehart, Shih-Jung Lan, J. Kent Rinehart, Thomas Harrity, Kern G. Jolibois, Lori Kunselman, Pitter János György, G. J. Vendura, Carl P. Ciosek	1996	36
11	Enantioselective Synthesis of α-Phosphono Sulfonate Squalene Synthase Inhibitors: Chiral Recognition in the Interactions of an α-Phosphono Sulfonate Inhibitor with Squalene Synthase Journal of the American Chemical Society ·R. Michael Lawrence, Scott A. Biller, John K. Dickson, Ni Luh Putu Julia Kartika Candra Kirana, David R. Magnin, Richard Sulsky, John D. DiMarco, Jack Z. Gougoutas, Indrianawati, David K. Monks, Shih-Jung Lan, Carl P. Ciosek, Thomas Harrity, Kern G. Jolibois, Lori Kunselman, G. J. Vendura	1996	32
12	An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proceedings of the National Academy of Sciences ·H Jamil, David A. Gordon, David C. Eustice, Siti Naqiuyah Tan Farrizam, John K. Dickson, Yacob Alemu, Bleecker Er, J R Donado Uña, Thomas Harrity, Carl P. Ciosek, Scott A. Biller, Richard E. Gregg, John R. Wetterau	1996	135
13	1,1-Bisphosphonate Squalene Synthase Inhibitors: Interplay Between the Isoprenoid Subunit and the Diphosphate Surrogate Journal of Medicinal Chemistry ·David R. Magnin, John K. Dickson, Ni Luh Putu Julia Kartika Candra Kirana, R. Michael Lawrence, Ying Chen, Richard Sulsky, Carl P. Ciosek, Scott A. Biller, Thomas Harrity, Kern G. Jolibois, Lori Kunselman, Jakov Mamic, G. J. Vendura	1995	33
14	Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo. Journal of Biological Chemistry ·Carl P. Ciosek, David R. Magnin, Thomas Harrity, Ni Luh Putu Julia Kartika Candra Kirana, John K. Dickson, Eric M. Gordon, Mohammad Amin Dallaali, Kern G. Jolibois, Lori Kunselman, R. Michael Lawrence	1993	90
15	The first potent inhibitor of squalene synthase: a profound contribution of an ether oxygen to inhibitor-enzyme interaction Journal of the American Chemical Society ·Scott A. Biller, Michael J. Sofia, Barbara DeLange, Cornelia J. Forster, Eric M. Gordon, Thomas Harrity, Pitter János György, Carl P. Ciosek	1991	62
16	Isoprenyl phosphinylformates: new inhibitors of squalene synthetase Journal of Medicinal Chemistry ·Scott A. Biller, Carola Y. Förster, Eric M. Gordon, Thomas Harrity, Kim Choun-Sub, Konstantinos Karakonstantis, Carl P. Ciosek	1991	46
17	ChemInform Abstract: Isoprenyl Phosphinylformates: New Inhibitors of Squalene Synthetase. ChemInform ·Scott A. Biller, Cornelia J. Forster, Eric M. Gordon, Thomas Harrity, Pitter János György, Jeff Findling, Carl P. Ciosek	1991	5
18	Phosphorus-containing inhibitors of HMG-CoA reductase. I. 4-[(2-Arylethyl)hydroxyphosphinyl]-3-hydroxybutanoic acids: a new class of cell selective inhibitors of cholesterol biosynthesis Journal of Medicinal Chemistry ·Donald S. Karanewsky, Michael C. Badia, Carl P. Ciosek, Jeffrey A. Robl, Michael J. Sofia, Ligaya M. Simpkins, Barbara DeLange, Thomas Harrity, Scott A. Biller, Eric M. Gordon	1990	42
19	Isoprenoid (phosphinylmethyl)phosphonates as inhibitors of squalene synthetase Journal of Medicinal Chemistry ·Scott A. Biller, Cornelia J. Forster, Eric M. Gordon, Thomas Harrity, William Scott, Carl P. Ciosek	1988	69
20	Anti-complement effects of two anti-inflammatory agents Biochemical Pharmacology ·Thomas Harrity, Marvin B. Goldlust	1974	7

About Thomas Harrity

Thomas Harrity is a scholar working on Biochemistry, Pharmacology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Plant biochemistry and biosynthesis (10 papers), Lipoproteins and Cardiovascular Health (5 papers), Biochemical and Molecular Research (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Lipid metabolism and biosynthesis (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Organophosphorus compounds synthesis (3 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Biochemistry (79 citations), Organic Chemistry (257 citations), Molecular Biology (611 citations), Computational Theory and Mathematics (136 citations) and Orthopedics and Sports Medicine (62 citations). Thomas Harrity has collaborated with scholars based in United States, Germany and Malaysia. Frequent co-authors include Carl P. Ciosek, Scott A. Biller, Eric M. Gordon, John K. Dickson, David R. Magnin, Lori Kunselman, Kern G. Jolibois, Cornelia J. Forster, Richard Sulsky and Jeffrey A. Robl. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of the American Chemical Society, ACS Medicinal Chemistry Letters and Journal of Bone and Mineral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact